WELLS FARGO & COMPANY/MN - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 36 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$504
-0.2%
5,632
+2.5%
0.00%
Q2 2023$505
-64.5%
5,492
+0.4%
0.00%
Q1 2023$1,423
-7.2%
5,471
-25.1%
0.00%
Q4 2022$1,533
+53.3%
7,300
+47.3%
0.00%
Q3 2022$1,000
-66.7%
4,955
+0.0%
0.00%
Q2 2022$3,000
-25.0%
4,954
-0.3%
0.00%
Q1 2022$4,000
-20.0%
4,967
-0.4%
0.00%
Q4 2021$5,000
-37.5%
4,9860.0%0.00%
Q3 2021$8,000
-11.1%
4,986
+0.2%
0.00%
Q2 2021$9,000
-10.0%
4,974
+0.1%
0.00%
Q1 2021$10,0000.0%4,971
+0.6%
0.00%
Q4 2020$10,000
-33.3%
4,941
-14.2%
0.00%
Q3 2020$15,000
-25.0%
5,761
+18.1%
0.00%
Q2 2020$20,000
+233.3%
4,877
-38.5%
0.00%
Q1 2020$6,000
-40.0%
7,930
+1.7%
0.00%
Q4 2019$10,000
+100.0%
7,7940.0%0.00%
Q3 2019$5,000
+25.0%
7,794
+14.7%
0.00%
Q2 2019$4,0006,7940.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q4 2020
NameSharesValueWeighting ↓
Allred Capital Management, LLC 52,926$113,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 109,940$236,0000.01%
PATHSTONE FAMILY OFFICE, LLC 10,050$22,0000.00%
Sowell Financial Services LLC 11,190$24,0000.00%
TWO SIGMA INVESTMENTS, LP 101,949$219,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 32,822$71,0000.00%
UBS Group AG 816$2,0000.00%
IFP Advisors, Inc 50$00.00%
OSAIC HOLDINGS, INC. 6$00.00%
Jacobi Capital Management LLC 1,000$2,0000.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders